Modulatory mechanisms of TARP γ8-selective AMPA receptor therapeutics.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
25 03 2023
Historique:
received: 23 07 2022
accepted: 09 03 2023
medline: 28 3 2023
entrez: 25 3 2023
pubmed: 26 3 2023
Statut: epublish

Résumé

AMPA glutamate receptors (AMPARs) mediate excitatory neurotransmission throughout the brain. Their signalling is uniquely diversified by brain region-specific auxiliary subunits, providing an opportunity for the development of selective therapeutics. AMPARs associated with TARP γ8 are enriched in the hippocampus, and are targets of emerging anti-epileptic drugs. To understand their therapeutic activity, we determined cryo-EM structures of the GluA1/2-γ8 receptor associated with three potent, chemically diverse ligands. We find that despite sharing a lipid-exposed and water-accessible binding pocket, drug action is differentially affected by binding-site mutants. Together with patch-clamp recordings and MD simulations we also demonstrate that ligand-triggered reorganisation of the AMPAR-TARP interface contributes to modulation. Unexpectedly, one ligand (JNJ-61432059) acts bifunctionally, negatively affecting GluA1 but exerting positive modulatory action on GluA2-containing AMPARs, in a TARP stoichiometry-dependent manner. These results further illuminate the action of TARPs, demonstrate the sensitive balance between positive and negative modulatory action, and provide a mechanistic platform for development of both positive and negative selective AMPAR modulators.

Identifiants

pubmed: 36966141
doi: 10.1038/s41467-023-37259-5
pii: 10.1038/s41467-023-37259-5
pmc: PMC10039940
doi:

Substances chimiques

TARP 0
Receptors, AMPA 0
Ligands 0
Calcium Channels 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1659

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH123474
Pays : United States
Organisme : NIMH NIH HHS
ID : R56 MH123474
Pays : United States
Organisme : Medical Research Council
ID : MRU105174197
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

Protein Sci. 2018 Jan;27(1):293-315
pubmed: 29067766
J Chem Phys. 2020 Jul 28;153(4):044130
pubmed: 32752662
ACS Med Chem Lett. 2019 Jan 23;10(3):228-236
pubmed: 30891118
J Physiol. 2021 Jan;599(2):397-416
pubmed: 32144935
Neuron. 2016 Sep 21;91(6):1305-1315
pubmed: 27618672
Nature. 2017 Sep 7;549(7670):60-65
pubmed: 28737760
J Pharmacol Exp Ther. 2019 Jun;369(3):345-363
pubmed: 30910921
Nat Commun. 2022 Feb 8;13(1):734
pubmed: 35136046
Elife. 2017 Aug 30;6:
pubmed: 28871958
J Mol Graph. 1996 Dec;14(6):354-60, 376
pubmed: 9195488
CNS Neurol Disord Drug Targets. 2008 Apr;7(2):129-43
pubmed: 18537642
Mol Pharmacol. 2022 May;101(5):343-356
pubmed: 35246481
Bioinformatics. 2013 Dec 15;29(24):3158-66
pubmed: 24078704
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67
pubmed: 21460454
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Sci Rep. 2016 Jun 06;6:27459
pubmed: 27264908
J Physiol. 2021 Jan;599(2):453-469
pubmed: 32004381
J Gen Physiol. 2020 Apr 6;152(4):
pubmed: 32221541
J Mol Biol. 1993 Dec 5;234(3):779-815
pubmed: 8254673
J Struct Biol. 2016 Jan;193(1):1-12
pubmed: 26592709
J Comput Chem. 2010 Mar;31(4):671-90
pubmed: 19575467
J Cell Biol. 2003 May 26;161(4):805-16
pubmed: 12771129
Neuron. 2017 Dec 6;96(5):989-1001
pubmed: 29216460
Science. 2014 Apr 18;344(6181):304-7
pubmed: 24744376
Nat Med. 2016 Dec;22(12):1496-1501
pubmed: 27820603
Protein Sci. 2006 Nov;15(11):2507-24
pubmed: 17075131
ACS Med Chem Lett. 2018 Oct 16;10(3):237-242
pubmed: 30891119
Curr Opin Pharmacol. 2015 Feb;20:46-53
pubmed: 25462292
Nature. 2021 Jun;594(7863):448-453
pubmed: 33981040
Cell Rep. 2012 Jun 28;1(6):590-8
pubmed: 22813734
Neuron. 2017 May 3;94(3):569-580.e5
pubmed: 28472657
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):777-81
pubmed: 8290599
Neuron. 2007 Sep 20;55(6):890-904
pubmed: 17880893
Bioinformatics. 2011 Jun 1;27(11):1575-7
pubmed: 21471012
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
Science. 2019 Dec 6;366(6470):1259-1263
pubmed: 31806817
Curr Opin Pharmacol. 2004 Feb;4(1):4-11
pubmed: 15018832
Acta Neurol Scand Suppl. 2013;(197):19-24
pubmed: 23480152
Sci Rep. 2017 Apr 21;7(1):1050
pubmed: 28432359
Nat Rev Drug Discov. 2020 Dec;19(12):884-901
pubmed: 33177699
Nat Rev Drug Discov. 2021 Sep;20(9):710-722
pubmed: 34257432
J Neurosci. 2015 Dec 09;35(49):16171-9
pubmed: 26658868
Curr Opin Struct Biol. 2019 Aug;57:185-195
pubmed: 31185364
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
Mol Pharmacol. 2019 Dec;96(6):835-850
pubmed: 31582576
Neuropharmacology. 2021 Oct 1;197:108709
pubmed: 34271020
J Pharmacol Exp Ther. 2014 Oct;351(1):124-33
pubmed: 25027316
Neuron. 2017 Mar 8;93(5):1126-1137.e4
pubmed: 28238551
J Biol Chem. 2020 Oct 23;295(43):14565-14577
pubmed: 32747446
Elife. 2018 Nov 09;7:
pubmed: 30412051
J Med Chem. 2016 May 26;59(10):4753-68
pubmed: 27067148
Neuron. 2014 Oct 01;84(1):41-54
pubmed: 25242221
Mol Cell. 2021 Dec 2;81(23):4771-4783.e7
pubmed: 34678168
J Pharmacol Exp Ther. 2016 May;357(2):394-414
pubmed: 26989142
Science. 2019 Apr 26;364(6438):
pubmed: 30872532
ACS Med Chem Lett. 2018 Dec 26;10(3):267-272
pubmed: 30891124
PLoS One. 2017 Mar 30;12(3):e0174742
pubmed: 28358902
Biochem Pharmacol. 2018 May;151:263-281
pubmed: 29330067
Neuron. 2017 May 17;94(4):713-730
pubmed: 28521126
Neuron. 2011 Apr 28;70(2):178-99
pubmed: 21521608
Nature. 2021 Nov;599(7884):325-329
pubmed: 34552241
J Chem Inf Model. 2011 Oct 24;51(10):2778-86
pubmed: 21919503
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
Mol Pharmacol. 2020 May;97(5):336-350
pubmed: 32111699
Nature. 2009 Dec 10;462(7274):745-56
pubmed: 19946266
Nat Methods. 2017 Jan;14(1):71-73
pubmed: 27819658
Nature. 2021 Jun;594(7863):454-458
pubmed: 34079129
Cell. 2017 Sep 7;170(6):1234-1246.e14
pubmed: 28823560
Neuron. 2012 May 24;74(4):621-33
pubmed: 22632720
J Physiol. 2017 Oct 15;595(20):6517-6539
pubmed: 28815591
Pharmacol Rev. 2021 Oct;73(4):298-487
pubmed: 34753794

Auteurs

Danyang Zhang (D)

Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK.

Remigijus Lape (R)

Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK.

Saher A Shaikh (SA)

Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK.

Bianka K Kohegyi (BK)

Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK.

Jake F Watson (JF)

Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK.
IST Austria, Klosterneuburg, Austria.

Ondrej Cais (O)

Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK.

Terunaga Nakagawa (T)

Department of Molecular Physiology and Biophysics, Vanderbilt University, School of Medicine, Nashville, USA.

Ingo H Greger (IH)

Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK. ig@mrc-lmb.cam.ac.uk.

Articles similaires

Receptor, Cannabinoid, CB1 Ligands Molecular Dynamics Simulation Protein Binding Thermodynamics
Proteins Protein Binding Ligands Internet Databases, Protein
1.00
Animals Caenorhabditis elegans Caenorhabditis elegans Proteins Feeding Behavior Social Behavior

Orientation-dependent CD45 inhibition with viral and engineered ligands.

Marta T Borowska, Liu D Liu, Nathanael A Caveney et al.
1.00
Leukocyte Common Antigens Humans Ligands T-Lymphocytes Viral Proteins

Classifications MeSH